5th Annual Cedars-Sinai Gastrointestinal Tumor Conference 2024
5th Annual Cedars-Sinai Gastrointestinal Tumor Conference 2024
Regular price
$15.00 USD
Regular price
$15.00 USD
Sale price
Unit price
per
Couldn't load pickup availability
5th Annual Cedars-Sinai Gastrointestinal Tumor Conference 2024
Regular price
$15.00
Regular price
$15.00
Sale price
Unit price
per
The 5th Annual Cedars-Sinai Gastrointestinal Tumor Conference will provide concise and comprehensive updates on the most recent research and advances in therapy for gastrointestinal cancers. A stellar faculty has been assembled to share developments in precision medicine, research, and immunotherapeutic approaches to the treatment of cancers of the pancreas, liver, and gastric/esophagus.
Include: 2 videos + 10 pdfs, size: 3.88 GB
+ Target Audience: Endocrinology & Metabolism, Family / General Medicine, Gastroenterology, Hepatology, Internal Medicine physician
+ Information:
Saturday, March 23, 2024, 7:30 AM – 12:30 PM PST, Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA
The 5th Annual Cedars-Sinai Gastrointestinal Tumor Conference will provide concise and comprehensive updates on the most recent research and advances in therapy for gastrointestinal cancers. A stellar faculty has been assembled to share developments in precision medicine, research, and immunotherapeutic approaches to the treatment of cancers of the pancreas, liver, and gastric/esophagus.
Invited faculty will present a comprehensive bench to bedside review of immune therapy for GI malignancies, detail immune therapies for pancreatic cancer, and explore advances in biomarkers and immunotherapy in gastroesophageal cancers. Biomarker strategies for neuroendocrine and rare tumors will be presented and participants will also have an opportunity to review immune-related toxicities. Join your colleagues for this important half day educational activity that will enhance your understanding of GI cancers and provide you with valuable information to inform your clinical decision-making and treatment approaches for your patients.
+Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
Include: 2 videos + 10 pdfs, size: 3.88 GB
+ Target Audience: Endocrinology & Metabolism, Family / General Medicine, Gastroenterology, Hepatology, Internal Medicine physician
+ Information:
Date & Location
Saturday, March 23, 2024, 7:30 AM – 12:30 PM PST, Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA
Target Audience
Specialties – Endocrinology & Metabolism, Family / General Medicine, Gastroenterology, Hepatology, Internal Medicine, Medical Genetics, Nuclear Medicine, Oncology, Pain Management, Palliative Care, Pathology & Laboratory Medicine, Radiation Oncology, Radiology
Professions – Nurse (Advanced Practice NP CRNA CNM CNS), Other (non-physician), Physician
Overview
The 5th Annual Cedars-Sinai Gastrointestinal Tumor Conference will provide concise and comprehensive updates on the most recent research and advances in therapy for gastrointestinal cancers. A stellar faculty has been assembled to share developments in precision medicine, research, and immunotherapeutic approaches to the treatment of cancers of the pancreas, liver, and gastric/esophagus.
Invited faculty will present a comprehensive bench to bedside review of immune therapy for GI malignancies, detail immune therapies for pancreatic cancer, and explore advances in biomarkers and immunotherapy in gastroesophageal cancers. Biomarker strategies for neuroendocrine and rare tumors will be presented and participants will also have an opportunity to review immune-related toxicities. Join your colleagues for this important half day educational activity that will enhance your understanding of GI cancers and provide you with valuable information to inform your clinical decision-making and treatment approaches for your patients.
Objectives
- Consider advances in biomarkers and therapy to better inform treatment decision-making for patients with gastroesophageal cancers
- Use AJCC or other appropriate staging in clinical practice, including the use of appropriate prognostic indicators and evidence-based national guidelines for treatment planning
- Evaluate the basic science of immune therapy for GI malignancies and the implications for transfer from bench to bedside
- Increase knowledge of therapy for neuroendocrine tumors and biomarker identification of novel therapies
- Identify and implement optimal strategies for managing therapy-related side effects and toxicities in patients treated with therapeutic agents
- Anticipate the needs, problems, and issues of cancer survivors and develop an individualized wellness plan in partnership with cancer survivors, their families and the healthcare team
+Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
- Agenda.pdf
- Cedars Sinai Cancer- Molecular Twin.pdf
- Cholangiocarcinoma and HCC.pdf
- How I approach TNT in Rectal Cancer.pdf
- Immunotherapy for GI Cancer.pdf
- Managment updates in Neuroendocrine tumors 2024.pdf
- March 23 Part 1.mp4
- March 23 Part 2.mp4
- Molecular Landscape in CRC- Shaping the Future.pdf
- Role of Social Media in Oncology Today.pdf
- The Challenges of Treating Pancreatic Cancer.pdf
- Update in Surgical Management of Gastric Cancer.pdf
*Detail:
Saturday, March 23, 2024
-
Introduction
8:00AM – 8:05AM
Andrew E Hendifar, MD
Arsen Osipov, MD
Jun Gong, MD
-
Molecular Landscape in CRC: Shaping the Future
8:05AM – 8:25AM
Marwan Fakih, MD
-
The Challenges of Treating Pancreatic Cancer
8:25AM – 8:45AM
Philip Philip, MD
-
Cholangiocarcinoma and HCC
8:45AM – 9:05AM
Anthony El-Khoueiry, MD
-
Update in Surgical Management of Gastric Cancer
9:05AM – 9:25AM
Miguel Burch, MD
-
Panel Discussion: GI Cancer Cases
9:25AM – 9:45AM
Anthony El-Khoueiry, MD
Edward Wolin, MD
Philip Philip, MD
Emily Nachtigal, MD (Panelist)
Vi K. Chiu, MD, PhD (Panelist)
Kambiz Kosari, MD
-
Break and Exhibits
9:45AM – 10:05AM
-
Novel approaches to targeting amino acid metabolism and the PI3K pathway in cancer
10:05AM – 10:25AM
Oliver DK Maddocks, MPharm, PhD
-
Cedars Sinai Cancer: Molecular Twin
10:25AM – 10:45AM
Dan Theodorescu, MD, PhD
-
How I approach TNT in Rectal Cancer
10:45AM – 11:05AM
Katelyn Atkins, MD, PhD
-
Managment updates in Neuroendocrine tumors 2024
11:05AM – 11:25AM
Edward Wolin, MD
-
Pick Up Lunch and Exhibits
11:25AM – 11:45AM
-
Immunotherapy for GI Cancer
11:45AM – 12:05PM
Joel R Hecht, MD
-
Role of Social Media in Oncology Today
12:05PM – 12:25PM
Tatiana Prowell, MD
-
Closing Remarks
12:25PM – 12:30PM
Andrew E Hendifar, MD
